Literature DB >> 35575928

HDL and microRNAs.

Hongtu Cui1, Kaixuan Lv2, Nana Yang3.   

Abstract

In previous chapters, we know that high-density lipoproteins (HDLs) could act at multiple cell lines and then trigger intracellular molecular pathway to prevent several metabolic diseases. Besides the classic genes regulating cholesterol efflux and reverse cholesterol transport (RCT), microRNAs (miRNAs) could also affect HDLs biogenesis, metabolism, and functions. This chapter summarizes the miRNAs, which regulate HDLs functions in table. In addition, HDLs are good vectors for miRNAs. They could carry miRNAs in circulation and take them into several cells such as macrophages and endothelial cells. Complete understanding of the miRNAs associated with HDL regulation would give us broader insights to prevent and treat metabolic diseases.
© 2022. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Circulating microRNAs; HDLs; Metabolic diseases; microRNAs

Mesh:

Substances:

Year:  2022        PMID: 35575928     DOI: 10.1007/978-981-19-1592-5_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  31 in total

1.  MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.

Authors:  Cristina M Ramirez; Alberto Dávalos; Leigh Goedeke; Alessandro G Salerno; Nikhil Warrier; Daniel Cirera-Salinas; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

2.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

3.  Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.

Authors:  Menno Hoekstra; Ronald J van der Sluis; Johan Kuiper; Theo J C Van Berkel
Journal:  J Nutr Biochem       Date:  2011-07-18       Impact factor: 6.048

4.  MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.

Authors:  Svenja Meiler; Yvonne Baumer; Emma Toulmin; Kosal Seng; William A Boisvert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12-18       Impact factor: 8.311

5.  MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.

Authors:  S Hani Najafi-Shoushtari; Fjoralba Kristo; Yingxia Li; Toshi Shioda; David E Cohen; Robert E Gerszten; Anders M Näär
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

6.  MicroRNA-20a/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1.

Authors:  Bin Liang; Xin Wang; Xiaosu Song; Rui Bai; Huiyu Yang; Zhiming Yang; Chuanshi Xiao; Yunfei Bian
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-08       Impact factor: 4.698

7.  MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7.

Authors:  Dongsheng Sun; Jun Zhang; Jianhong Xie; Wei Wei; Mantao Chen; Xiang Zhao
Journal:  FEBS Lett       Date:  2012-04-18       Impact factor: 4.124

8.  MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Tammy Kim; Mete Civelek; Ángel Baldán; Christine Esau; Peter A Edwards
Journal:  Circ Res       Date:  2013-03-21       Impact factor: 17.367

9.  Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis.

Authors:  Y K Adlakha; S Khanna; R Singh; V P Singh; A Agrawal; N Saini
Journal:  Cell Death Dis       Date:  2013-08-29       Impact factor: 8.469

10.  The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.

Authors:  Shuo Geng; Keqiang Chen; Ruoxi Yuan; Liang Peng; Urmila Maitra; Na Diao; Chun Chen; Yao Zhang; Yuan Hu; Chen-Feng Qi; Susan Pierce; Wenhua Ling; Huabao Xiong; Liwu Li
Journal:  Nat Commun       Date:  2016-11-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.